118 related articles for article (PubMed ID: 21229643)
1. Radiosensitization of hormone-refractory prostate cancer cells by gossypol treatment.
Akagunduz O; Karaca B; Atmaca H; Uzunoglu S; Karabulut B; Sanli UA; Haydaroglu A; Uslu R
J BUON; 2010; 15(4):763-7. PubMed ID: 21229643
[TBL] [Abstract][Full Text] [Related]
2. (-)-Gossypol reduces invasiveness in metastatic prostate cancer cells.
Huang YW; Wang LS; Dowd MK; Wan PJ; Lin YC
Anticancer Res; 2009 Jun; 29(6):2179-88. PubMed ID: 19528479
[TBL] [Abstract][Full Text] [Related]
3. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
Pchejetski D; Bohler T; Brizuela L; Sauer L; Doumerc N; Golzio M; Salunkhe V; TeissiƩ J; Malavaud B; Waxman J; Cuvillier O
Cancer Res; 2010 Nov; 70(21):8651-61. PubMed ID: 20959468
[TBL] [Abstract][Full Text] [Related]
4. (-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer.
Xu L; Yang D; Wang S; Tang W; Liu M; Davis M; Chen J; Rae JM; Lawrence T; Lippman ME
Mol Cancer Ther; 2005 Feb; 4(2):197-205. PubMed ID: 15713891
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells.
Huang YW; Wang LS; Chang HL; Ye W; Dowd MK; Wan PJ; Lin YC
Anticancer Res; 2006; 26(3A):1925-33. PubMed ID: 16827126
[TBL] [Abstract][Full Text] [Related]
6. AT-101 (R-(-)-gossypol acetic acid) enhances the effectiveness of androgen deprivation therapy in the VCaP prostate cancer model.
McGregor N; Patel L; Craig M; Weidner S; Wang S; Pienta KJ
J Cell Biochem; 2010 Aug; 110(5):1187-94. PubMed ID: 20589722
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis by (-)-gossypol-enriched cottonseed oil in human breast cancer cells.
Ye W; Chang HL; Wang LS; Huang YW; Shu S; Sugimoto Y; Dowd MK; Wan PJ; Lin YC
Int J Mol Med; 2010 Jul; 26(1):113-9. PubMed ID: 20514430
[TBL] [Abstract][Full Text] [Related]
8. Redox modulation of human prostate carcinoma cells by selenite increases radiation-induced cell killing.
Husbeck B; Peehl DM; Knox SJ
Free Radic Biol Med; 2005 Jan; 38(1):50-7. PubMed ID: 15589371
[TBL] [Abstract][Full Text] [Related]
9. Targeting apoptosis in the hormone- and drug-resistant prostate cancer cell line, DU-145, by gossypol/zoledronic acid combination.
Sanli UA; Gorumlu G; Erten C; Gul MK; Cengiz E; Kucukzeybek Y; Karaca B; Atmaca H; Uzunoglu S; Karabulut B; Uslu R
Cell Biol Int; 2009 Nov; 33(11):1165-72. PubMed ID: 19716895
[TBL] [Abstract][Full Text] [Related]
10. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.
An J; Chervin AS; Nie A; Ducoff HS; Huang Z
Oncogene; 2007 Feb; 26(5):652-61. PubMed ID: 16909121
[TBL] [Abstract][Full Text] [Related]
11. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
Shankar S; Singh TR; Srivastava RK
Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092
[TBL] [Abstract][Full Text] [Related]
12. Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation.
Cao W; Yacoub S; Shiverick KT; Namiki K; Sakai Y; Porvasnik S; Urbanek C; Rosser CJ
Prostate; 2008 Aug; 68(11):1223-31. PubMed ID: 18465755
[TBL] [Abstract][Full Text] [Related]
13. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
Cuellar DC; Rhee J; Kyprianou N
Anticancer Res; 2002; 22(3):1673-9. PubMed ID: 12168853
[TBL] [Abstract][Full Text] [Related]
14. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization of tumour cell lines by the polyphenol Gossypol results from depressed double-strand break repair and not from enhanced apoptosis.
Kasten-Pisula U; Windhorst S; Dahm-Daphi J; Mayr G; Dikomey E
Radiother Oncol; 2007 Jun; 83(3):296-303. PubMed ID: 17521756
[TBL] [Abstract][Full Text] [Related]
16. The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.
Pajonk F; Himmelsbach J; Riess K; Sommer A; McBride WH
Cancer Res; 2002 Sep; 62(18):5230-5. PubMed ID: 12234989
[TBL] [Abstract][Full Text] [Related]
17. Sodium selenite radiosensitizes hormone-refractory prostate cancer xenograft tumors but not intestinal crypt cells in vivo.
Tian J; Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):230-6. PubMed ID: 20615620
[TBL] [Abstract][Full Text] [Related]
18. Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.
Kong Z; Raghavan P; Xie D; Boike T; Burma S; Chen D; Chakraborty A; Hsieh JT; Saha D
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1210-8. PubMed ID: 20970033
[TBL] [Abstract][Full Text] [Related]
19. A combined regimen of gossypol plus methyltestosterone and ethinylestradiol as a contraceptive induces germ cell apoptosis and expression of its related genes in rats.
Cui GH; Xu ZL; Yang ZJ; Xu YY; Xue SP
Contraception; 2004 Oct; 70(4):335-42. PubMed ID: 15451339
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibitor bortezomib increases radiation sensitivity in androgen independent human prostate cancer cells.
Goktas S; Baran Y; Ural AU; Yazici S; Aydur E; Basal S; Avcu F; Pekel A; Dirican B; Beyzadeoglu M
Urology; 2010 Apr; 75(4):793-8. PubMed ID: 19800672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]